» Articles » PMID: 35985686

A Novel Cryptic T(2;3)(p21;q25) Translocation Fuses the and Genes in Uterine Leiomyoma With 3q- As the Sole Visible Chromosome Abnormality

Overview
Date 2022 Aug 19
PMID 35985686
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aim: Deletions in the q arm of chromosome 3 have been reported in uterine leiomyomas, also as sole anomalies. Because some neoplasia-associated deletions may give rise to tumorigenic fusion genes, we chose to investigate thoroughly one such tumor.

Materials And Methods: A uterine leiomyoma obtained from a 45-year-old woman had the karyotype 46,XX,del(3)(q?)[11]. The tumor was further studied using array comparative genomic hybridization, RNA sequencing, reverse transcription polymerase chain reaction, Sanger sequencing, and fluorescence in situ hybridization methodologies.

Results: The deletion was shown to be from 3q22.2 to 3q26.32. Unexpectedly, a cryptic balanced t(2;3)(p21;q25) translocation was also found affecting two otherwise normal chromosomes 2 and 3, i.e., the der(3)t(2;3) was not the deleted chromosome 3. The translocation generated two chimeras between the genes WW domain containing transcription regulator 1 (WWTR1) from 3q25.1 and protein kinase C epsilon (PRKCE) from 2p21. The WWTR1::PRKCE fusion would code for a chimeric serine/threonine kinase, whereas the reciprocal PRKCE::WWTR1 fusion would code for a chimeric transcriptional coactivator protein.

Conclusion: Leiomyomas carrying a deletion on 3q may also have a balanced t(2;3)(p21;q25) leading to fusion of WWTR1 with PRKCE.

Citing Articles

Genetic Pathways in Peritoneal Mesothelioma Tumorigenesis.

Panagopoulos I, Andersen K, Brunetti M, Gorunova L, Davidson B, Lund-Iversen M Cancer Genomics Proteomics. 2023; 20(4):363-374.

PMID: 37400148 PMC: 10320557. DOI: 10.21873/cgp.20388.


Acute Undifferentiated Leukemia With a Balanced t(5;10)(q35;p12) Resulting in Fusion of With .

Panagopoulos I, Andersen K, Wik H, Tandsaether M, Micci F, Heim S Cancer Genomics Proteomics. 2023; 20(4):354-362.

PMID: 37400142 PMC: 10320562. DOI: 10.21873/cgp.20387.


Recurrent 8q11-13 Aberrations Leading to Rearrangements, Including Novel Chimeras and , in Lipomatous Tumors.

Panagopoulos I, Andersen K, Gorunova L, Lund-Iversen M, Lobmaier I, Micci F Cancer Genomics Proteomics. 2023; 20(2):171-181.

PMID: 36870688 PMC: 9989671. DOI: 10.21873/cgp.20372.


Novel and Fusion Genes in T-cell Acute Lymphoblastic Leukemia.

Panagopoulos I, Andersen K, Johannsdottir I, Micci F, Heim S Cancer Genomics Proteomics. 2022; 20(1):51-63.

PMID: 36581344 PMC: 9806666. DOI: 10.21873/cgp.20364.


Fusion of the and Genes in Uterine Leiomyoma With t(9;12)(p22;q14).

Panagopoulos I, Andersen K, Gorunova L, Davidson B, Micci F, Heim S In Vivo. 2022; 36(6):2654-2661.

PMID: 36309352 PMC: 9677776. DOI: 10.21873/invivo.13000.

References
1.
Nilbert M, Heim S, Mandahl N, Floderus U, Willen H, Mitelman F . Characteristic chromosome abnormalities, including rearrangements of 6p, del(7q), +12, and t(12;14), in 44 uterine leiomyomas. Hum Genet. 1990; 85(6):605-11. DOI: 10.1007/BF00193583. View

2.
Panagopoulos I, Gorunova L, Andersen K, Lund-Iversen M, Lobmaier I, Micci F . and Fusion Genes in Chondroid Syringoma. Cancer Genomics Proteomics. 2020; 17(3):237-248. PMC: 7259886. DOI: 10.21873/cgp.20184. View

3.
Pandis N, Heim S, Bardi G, Floderus U, Willen H, Mandahl N . Chromosome analysis of 96 uterine leiomyomas. Cancer Genet Cytogenet. 1991; 55(1):11-8. DOI: 10.1016/0165-4608(91)90229-n. View

4.
Christacos N, Quade B, Dal Cin P, Morton C . Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features. Genes Chromosomes Cancer. 2005; 45(3):304-12. DOI: 10.1002/gcc.20291. View

5.
Panagopoulos I, Heim S . Interstitial Deletions Generating Fusion Genes. Cancer Genomics Proteomics. 2021; 18(3):167-196. PMC: 8126330. DOI: 10.21873/cgp.20251. View